We are committed to drawing upon the best quality evidence about racial and ethnic inequality in health. This means not only commissioning original research to fill knowledge gaps, but also synthesising and mobilising existing evidence.
The Cost of Racism is a programme of work exploring the ways in which racism and race inequity lead to significant and avoidable cost to the healthcare service and our economy.
Familial hypercholesterolemia is a disorder that is typically inherited from a parent causing high cholesterol levels. Without treatment, it can cause early heart attacks along with a higher risk of heart disease.
At the frontier of medical innovation, technologies promise to make healthcare more personalised, more efficient, and safer.
The scope of this work is to provide insights that will help to promote effective and respectful communication with ethnic minority women and pregnant people.
Trauma informed care has been increasingly explored within services over recent years both in health and social care, as well as criminal justice. Broadly speaking, a trauma-informed approach to care can be described as one which ‘aims to provide an environment where a person who has experienced trauma feels safe and can develop trust’.
Pharmacogenomics is the study of how genetic variation affects responses to drugs. This includes both the efficacy and safety of drugs.
